Jointly provided by Postgraduate Institute for Medicine and Enquiring Minds
Supported by an independent educational grant from Sanofi Genzyme
Make real-world decisions and customize treatment plans in this dynamic case-based activity.
This activity is intended for physicians engaged in the care of patients with multiple sclerosis (MS).
Upon completion of the activity, participants should be better able to:
Evaluate and appropriately apply the latest clinical evidence and recommendations when safely and effectively integrating current and emerging therapies into treatment plans for MS
Employ patient-centered approaches when determining barriers to optimal therapeutic response and strategies to overcome them
Conflict Of Interest Disclosure Policy
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Andrew J. Solomon, MD Associate Professor of Neurological Sciences Division Chief, Multiple Sclerosis University of Vermont College of Medicine Burlington, VT
Dr. Solomon discloses the following: Consulting Fees: Genentech, EMD Serono, Teva, Biogen
Stephen Krieger, MD Associate Professor of Neurology Director, Neurology Residency Program Icahn School of Medicine at Mount Sinai New York, NY
Dr. Krieger discloses the following: Consulting Fees: Acorda, Bayer, Biogen, EMD Serono, Genentech, Genzyme, Mallinckrodt, Novartis, Teva Contracted Research: MedDat, TG Therapeutics Fees from Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Biogen and Genentech
Accredited Provider Disclosures
Planners and Managers The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN, and Jan Schultz, RN, MSN, CHCP, have nothing to disclose. The Enquiring Minds, LLC medical writers, Karen Chiu and Emma Nichols, PhD, have nothing to disclose.
AMA PRA Category 1 Credit(s)TM
In support of improving patient care, these activities have been planned and implemented by the Postgraduate Institute for Medicine and Enquiring Minds. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
In order to receive credit, participants must complete the program evaluation. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.
For information about the accreditation of this program, please contact firstname.lastname@example.org.